CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 12 enrolled
Drug / intervention
celecoxib (Celebrex) +1 moredrug
Likely dose
celecoxib (Celebrex) 100 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00624559
NCT00624559Phase 4Completed
CompareCT.gov

COX-2 Regulation of Renal Sodium Handling in Blood Pressure Maintenance

University of Delaware·interventional·Posted Feb 27, 2008·Updated Jan 6, 2012

In Brief

A Phase 4 clinical trial evaluating celecoxib (Celebrex) and Placebo for Hypertension. Completed, enrolled 12 participants across 1 site.

Detailed Summary

The purpose of this study is to determine if the drug Celebrex changes the way the kidney gets rid of salt and maintains blood pressure.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHypertension
CountriesUnited States
CollaboratorsChristiana Care Health Services

Timeline

Phase 4CompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedFeb 27, 2008
Enrollment StartFeb 1, 2008
Primary CompletionJan 1, 2009
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 18.3 years ago

Interventions

celecoxib (Celebrex)drug

Celecoxib (Celebrex) was administered at 100 mg, twice per day for each day of sodium diet

Placeboother

Placebo pill taken twice per day on each day of the diet